Le Lézard
Classified in: Health
Subjects: PDT, MAT

California Based Lifestyle & Cannabis Brand, Cookies, To Launch Exclusive "Gary Payton" Strain Named After Hall Of Fame Basketball Player


SAN FRANCISCO, July 11, 2019 /PRNewswire/ -- Cookies, the leading lifestyle and cannabis brand in North America, is pleased to announce the launch of "Gary Payton," a unique strain of cannabis named after the legendary Seattle SuperSonics and Naismith Memorial Basketball Hall of Fame player, Gary Payton. The exclusive deal, which includes the licensing of Gary Payton's name and image, is part of a joint venture with Powerzzz Genetics, creator of this particular strain.

"Gary Payton" by Cookies

"Kenny & J just finished a pheno hunt with some of our new favorite crosses.  We all sat down, as usual, and started to smoke through the new flower. The #20 stood out big time and naturally Kenny called it 'That Gary Payton,'" says Berner, Cookies founder and CEO.  "Lots of people have been waiting on the Snowman and the Y, so the cross was instantly hyped. We spread the #20 out with our friends and everyone shared it on social media tagging 'Gary Payton'. Oddly enough, Gary and I had mutual friends who set up a meeting in Oakland. The vibe was right and we both decided to change the game together. Think about it: this is like the Wheaties box for the weed game and we were the first to pop it off.  What makes it best is the bag behind it is so fire."

"Cookies and Gary Payton both having roots in Seattle make this collaboration special," says Gary Vaynerchuk, Partner at Green Street. "It's a first for someone like Gary (Payton) with such an accomplished athletic career to have their own cannabis strain and this really shows how open he is to completely new business and branding opportunities. Marketing for a cannabis brand has so much regulation, and connecting a leading brand with someone who is culturally relevant is a smart move for them both."

"Gary Payton" is now available at Cookies retail locations throughout California and Cookies retailers in Michigan will release "Gary Payton" in August.

ABOUT COOKIES
Cookies was founded in 2012 by Berner, the prolific Bay Area rapper and entrepreneur, and his partner Jigga, Bay Area cultivator and breeder.  The combination of new genetics, the internet, music and being one of the first companies to establish an identity and streetwear company based on the brand represents a priceless time that may never come back.  With the music industry backing Cookies and social media and YouTube vlogs documenting the growth of Cookies and breeding projects, the community was able to take that ride with the brand which build a grassroots cult following.

Today, Cookies is one of the most respected and top-selling cannabis brands in California and is globally recognized, amassing a stable of over 50 cannabis varieties and product lines including indoor, outdoor and sungrown flower, pre-rolls, gel caps and vape carts.  With two flagship Cookies stores in Los Angeles on Melrose and Maywood and a third location in Redding, Cookies' overall vertical integration and seed to sale business allows for complete quality control at every step from cultivation and production to retail experience.

In 2015, the brand's hip-hop credibility effortlessly expanded Cookies into streetwear and today offers a range of products for both men and women in the apparel and accessories categories as well as a curated selection of smoking supplies.

To learn more, please visit www.cookiescalifornia.com.  For Berner's full bio, interview requests, and more information please contact [email protected].

 

Cookies Logo (PRNewsfoto/Cookies)

SOURCE Cookies


These press releases may also interest you

at 06:32
"According to the latest BCC Research study, the demand for Medical Robotics and Computer-assisted Surgery: The Global Market is expected to grow from $11.5 billion in 2023 and is projected to reach $19.5 billion by the end of 2028, at a compound...

at 06:15
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients may benefit from longer-term treatment with debamestrocel...

at 06:00
Ibex Medical Analytics (Ibex), a global leader in AI-powered cancer diagnostics, and Kameda Medical Center (Kameda), a leading Japanese institute at the pinnacle of healthcare innovation, today announced the publication of a clinical study evaluating...



News published on and distributed by: